Enhancement of the release of inflammatory mediators by substance P in rat basophilic leukemia RBL-2H3 cells

Journal of Biomedical Science

Volumn 13, Issue 5, 2006, Pages 613-619

  Liao, Ben Ching ^a   Hou, Rolis Chien Wei ^b   Wang, Jen Shu ^c,d   Jeng, Kee Ching G ^a,d  

^a NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^b JEN TEH JUNIOR COLLEGE OF MEDICINE   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Allergen; Ginsenoside Rb1; Histamine; Interleukin 4; Leukotriene C4; Mitogen activated protein kinases; RBL 2H3 cells; Substance P

Indexed keywords

2,4 DINITROPHENOL; ALLERGEN; BOVINE SERUM ALBUMIN; GINSENOSIDE RB 1; IMMUNOGLOBULIN E; INTERLEUKIN 4; LEUKOTRIENE C4; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; SUBSTANCE P;

ANIMAL CELL; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOTOXICITY; DRUG EFFECT; DRUG MECHANISM; HISTAMINE RELEASE; LEUKEMIA CELL; MAST CELL LEUKEMIA; MEDIATOR RELEASE; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANIMALS; ANTI-ALLERGIC AGENTS; CELL LINE; GINSENOSIDES; INFLAMMATION MEDIATORS; MAP KINASE SIGNALING SYSTEM; NEUROGENIC INFLAMMATION; RATS; SERUM ALBUMIN, BOVINE; SIGNAL TRANSDUCTION; SUBSTANCE P;

BOS TAURUS; PANAX GINSENG;

EID: 33749327496     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1007/s11373-006-9099-1     Document Type: Article

References (37)

1. Kraneveld A.D. and Nijkamp F.P., Tachykinins and neuro-immune interactions in asthma. Int. Immunopharmacol. 1: 1629-1650, 2001.
2. Groneberg D.A., Quarcoo D., Frossard N. and Fischer A., Neurogenic mechanisms in bronchial inflammatory diseases. Allergy 59: 1139-1152, 2004.
3. Dinh Q.T., Groneberg D.A., Peiser C., Mingomataj E., Joachim R.A., Witt C., Arck P.C., Klapp B.F. and Fischer A., Substance P expression in TRPV1 and trkA-positive dorsal root ganglion neurons innervating the mouse lung. Respir. Physiol. Neurobiol. 144: 15-24, 2004.
4. Heaney L.G., Cross L.J., Stanford C.F. and Ennis M., Substance P induces histamine release from human pulmonary mast cells. Clin. Exp. Allergy 25: 179-186, 1995.
5. Lau A.H., Chow S.S. and Ng Y.S., Immunologically induced histamine release from rat peritoneal mast cells is enhanced by low levels of substance P. Eur. J. Pharmacol. 414: 295-303, 2001.
6. Maghni K., Taha R., Afif W., Hamid Q. and Martin J.G., Dichotomy between neurokinin receptor actions in modulating allergic airway responses in an animal model of helper T cell type 2 cytokine-associated inflammation. Am. J. Respir. Crit. Care Med. 162: 1068-1074, 2000.
7. Maezawa Y., Nakajima H., Kumano K., Kubo S., Karasuyama H. and Iwamoto I., Role of IgE in Th2 cell-mediated allergic airway inflammation. Int. Arch. Allergy Immunol. 131(Suppl 1) 2-6, 2003.
8. Khodoun M.V., Orekhova T., Potter C., Morris S. and Finkelman F.D., Basophils initiate IL-4 production during a memory T-dependent response. J. Exp. Med. 200: 857-870, 2004.
9. Nayak A., A review of montelukast in the treatment of asthma and allergic rhinitis. Expert Opin. Pharmacother. 5: 679-686, 2004.
10. Mechiche H., Naline E., Candenas L., Pinto F.M., Birembault P., Advenier C. and Devillier P., Effects of cysteinyl leukotrienes in small human bronchus and antagonist activity of montelukast and its metabolites. Clin. Exp. Allergy 33: 887-894, 2003.
11. Cai Y., Bjermer L. and Halstensen T.S., Bronchial mast cells are the dominating LTC4S-expressing cells in aspirin-tolerant asthma. Am. J. Respir. Cell Mol. Biol. 29: 683-693, 2003.
12. Leff A.R., Regulation of leukotrienes in the management of asthma: biology and clinical therapy. Annu. Rev. Med. 52: 1-14, 2001.
13. 4 in substance P-induced itch-associated response in mice. J. Invest. Dermatol. 117: 1621-1626, 2001.
14. Radad K., Gille G., Moldzio R., Saito H. and Rausch W.D., Ginsenosides Rb1 and Rg1 effects on mesencephalic dopaminergic cells stressed with glutamate. Brain Res. 1021: 41-53, 2004.
15. Park E.K., Choo M.K., Kim E.J., Han M.J. and Kim D.H., Antiallergic activity of ginsenoside Rh2. Biol. Pharm. Bull. 26: 1581-1584, 2003.
16. Park E.K., Shin Y.W., Lee H.U., Kim S.S., Lee Y.C., Lee B.Y. and Kim D.H., Inhibitory effect of ginsenoside Rb1 and compound K on NO and prostaglandin E2 biosyntheses of RAW264.7 cells induced by lipopolysaccharide. Biol. Pharm. Bull. 28: 652-656, 2005.
17. Ro J.Y., Ahn Y.S. and Kim K.H., Inhibitory effect of ginsenoside on the mediator release in the guinea pig lung mast cells activated by specific antigen-antibody reactions. Int. J. Immunopharmacol. 20: 625-641, 1998.
18. Yoshimura T., Kaneuchi T., Miura T. and Kimura M., Kinetic analysis of the fluorescence reaction of histamine with orthophthalaldehyde. Anal. Biochem. 164: 132-137, 1987.
19. Iwaki S., Ogasawara M., Kurita R., Niwa O., Tanizawa K., Ohashi Y. and Maeyama K., Real-time monitoring of histamine released from rat basophilic leukemia (RBL-2H3) cells with a histamine microsensor using recombinant histamine oxidase. Anal. Biochem. 304: 236-243, 2002.
20. Togias A., Unique mechanistic features of allergic rhinitis. J. Allergy Clin. Immunol. 105: S599-604, 2000.
21. Kudlacz E.M., Combined tachykinin receptor antagonists for the treatment of respiratory diseases. Expert Opin. Investig. Drugs 7: 1055-1062, 1998.
22. O'Connor T.M., O'Connell J., O'Brien D.I., Goode T., Bredin C.P. and Shanahan F., The role of substance P in inflammatory disease. J. Cell Physiol. 201: 167-180, 2004.
23. Chuaychoo B., Hunter D.D., Myers A.C., Kollarik M. and Undem B.J., Allergen-induced substance P synthesis in large-diameter sensory neurons innervating the lungs. J. Allergy Clin. Immunol. 116: 325-331, 2005.
24. Guhl S., Lee H.H., Babina M., Henz B.M. and Zuberbier T., Evidence for a restricted rather than generalized stimulatory response of skin-derived human mast cells to substance P. J. Neuroimmunol. 163: 92-101, 2005.
25. Bischoff S.C., Schwengberg S., Lorentz A., Manns M.P., Bektas H., Sann H., Levi-Schaffer F., Shanahan F. and Schemann M., Substance P and other neuropeptides do not induce mediator release in isolated human intestinal mast cells. Neurogastroenterol. Motil. 16: 185-193, 2004.
26. Karimi K., Kool M., Nijkamp F.P. and Redegeld F.A., Substance P can stimulate prostaglandin D2 and leukotriene C4 generation without granule exocytosis in murine mast cells. Eur. J. Pharmacol. 489: 49-54, 2004.
27. Azzolina A., Bongiovanni A. and Lampiasi N., Substance P induces TNF-alpha and IL-6 production through NF kappa B in peritoneal mast cells. Biochim. Biophys. Acta 1643: 75-83, 2003.
28. Bradding P., Feather I.H., Howarth P.H., Mueller R., Roberts J.A., Britten K., Bews J.P., Hunt T.C., Okayama Y. and Heusser C.H., Interleukin 4 is localized to and released by human mast cells. J. Exp. Med. 1176: 1381-1386, 1992.
29. Bradding P., Roberts J.A., Britten K.M., Montefort S., Djukanovic R., Mueller R., Heusser C.H., Howarth P.H. and Holgate S.T., Interleukin-4, -5, and -6 and tumor necrosis factor-alpha in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines. Am. J. Respir. Cell Mol. Biol. 10: 471-480, 1994.
30. Wilson S.J., Shute J.K., Holgate S.T., Howarth P.H. and Bradding P., Localization of interleukin (IL)-4 but not IL-5 to human mast cell secretory granules by immunoelectron microscopy. Clin. Exp. Allergy 30: 493-500, 2000.
31. Kabesch M., Schedel M., Carr D., Woitsch B., Fritzsch C., Weiland S.K. and von Mutius E., IL-4/IL-13 pathway genetics strongly influence serum IgE levels and childhood asthma. J. Allergy Clin. Imm. 117: 269-274, 2006.
32. Saito H., Suda K., Schwab M. and Thoenen H., Potentiation of the NGF-mediated nerve fiber outgrowth by ginsenoside Rb1 in organ cultures of chicken dorsal root ganglia. Jpn. J. Pharmacol. 27: 445-451, 1997.
33. Benishin C.G., Actions of ginsenoside Rb1 on choline uptake in central cholinergic nerve endings. Neurochem. Int. 21: 1-5, 1992.
34. Chue S.C., Seow C.J., Duan W., Yeo K.S., Koh A.H. and Wong W.S., Inhibitor of p42/44 mitogen-activated protein kinase, but not p38 MAPK, attenuated antigen challenge of guinea pig airways in vitro. Int. Immunopharmacol. 4: 1089-1098, 2004.
35. Azzolina A., Guarneri P. and Lampiasi N., Involvement of p38 and JNK MAPKs pathways in Substance P-induced production of TNF-α by peritoneal mast cells. Cytokine 18: 72-80, 2002.
36. Gibbs B.F., Wolff H.H., Zillikens D. and Grabbe J., Differential role for mitogen-activated protein kinases in IgE-dependent signaling in human peripheral blood basophils: in contrast to p38 MAPK, c-Jun N-terminal kinase is poorly expressed and does not appear to control mediator release. Int. Arch. Allergy Immunol. 136: 329-339, 2005.
37. Walsh G.M., Novel therapies for asthma- advances and problems. Curr. Pharm. Des. 11: 3027-3038, 2005.